Why is Boston Bio falling/rising?

As of 22-Aug, Boston Bio Systems Ltd's stock price is currently at 7.96, reflecting an increase of 0.35 or 4.6%. The stock has shown a positive trend today, outperforming its sector by 1.12% and reversing a two-day decline. Over the past week, the stock has gained 0.76%, and it has significantly outperformed the benchmark over the past month with a return of 11.95% compared to the Sensex's decline of 1.07%. However, there has been a notable decrease in investor participation, with delivery volume falling by 37.26% against the five-day average, which may indicate reduced trading interest despite the stock's upward movement.
Broader Market Context: In the context of the broader market, the medical equipment sector has gained by 3.83%, contributing positively to Boston Bio's performance. While the stock has outperformed the benchmark in the short term, the overall market sentiment appears mixed, as indicated by the Sensex's modest gain of 0.88% over the past week. The stock's liquidity remains adequate for trading, but the falling delivery volume could suggest caution among investors, potentially impacting future price movements.